European Archives - Page 819 of 1166 - European Medical Journal

Prognostic Role of Cardiac Power Index in Patients with Biopsy-Proven Inflammatory Cardiomyopathy

Most patients with acute myocarditis and mild cardiac involvement recover without long-term sequelae. However, those patients with advanced cardiac…

Treatment of Chronic Chagasic Patients: Is Killing the Parasite the Only Option?

Chronic Chagasic cardiomyopathy (CCC) is one of the principal challenges for clinicians treating asymptomatic Chagasic patients. Only benznidazole (BZ)…

Risk Stratification and Age-Adjusted D-Dimer Test: Are They Satisfactory in Acute Pulmonary Embolism?

Pulmonary embolism (PE) is associated with high morbidity and mortality and often has a nonspecific clinical presentation; thus, prognostic assessment…

An interview with Giles Platford from Takeda

An interview with Giles Platford, President Europe & Canada, Takeda Pharmaceutical Company Limited at the eyeforpharma conference, Barcelona, 2018. Mr Platford discusses Takeda’s Patient-Trust-Reputation-Business decision-making model to ensure the patient is at the heart of everything and what it takes to successfully manage a team and inspire innovation, while striving for sustainable business growth.

Quality of Life and Psychosocial Issue in Skin Disease

Awareness of the impact that skin diseases can have on a patients’ quality of life has improved markedly within the dermatology community in recent…

First-of-its-Kind Topical Spray Proving Effective at Treating Atopic Dermatitis

Cyclatop, a 5% cyclosporine topical spray, may be poised to deliver a significant therapeutic improvement for atopic dermatitis patients. A new study by…

Beauticians Beware: (Meth)acrylate May Cause Contact Allergy

(Meth)acrylates are important components of acrylic nails, gel nails, and gel polish nails and could be the cause of an allergic epidemic, warns a…

EMJ Oncology 6 [Suppl 1] 2018

Dr Oaknin welcomed the delegates to the symposium and presented the objectives and agenda for the meeting as well as a case study presentation. Dr Birrer…

The Role of PARP Inhibitors in Ovarian Cancer: An Emerging Picture

Dr Birrer presented on the current landscape of platinum-sensitive recurrent ovarian cancer (PSR OC), including USA and European treatment guidelines.

FutureNova wins prestigious Plastics Industry Award

Chelmsford based FutureNova is celebrating having won Consumer product Design of the Year at the prestigious Plastics Industry Award for its innovative…